Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
45%
OVERLAP
BY WEIGHT
25
# OF OVERLAPPING
HOLDINGS
XUHC.DE
58
HOLDINGS
43%
ALSO IN XDG3.DE
XDG3.DE
111
HOLDINGS
23%
ALSO IN XUHC.DE
SECTOR DRIFT (XUHC.DE minus XDG3.DE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XUHC.DE |
Weight in XDG3.DE |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 14.9% | 5.0% | 5.0% |
|
MERCK & CO. INC. | 5.2% | 4.8% | 4.8% |
|
ABBVIE INC | 6.9% | 4.6% | 4.6% |
|
AMGEN INC | 3.3% | 4.6% | 3.3% |
|
THERMO FISHER SCIENTIFIC INC | 3.1% | 4.0% | 3.1% |
XUHC.DE Overweight Relative to XDG3.DE
|
JOHNSON & JOHNSON | 10.3% |
|
ELI LILLY & CO | 10.0% |
|
UNITEDHEALTH GROUP INC | 6.7% |
|
INTUITIVE SURGICAL INC | 2.8% |
|
PFIZER INC | 2.7% |
|
CVS CAREMARK CORP | 2.3% |
|
ABBVIE INC | 2.3% |
|
MCKESSON CORP | 1.7% |
|
ELEVANCE HEALTH INC | 1.6% |
|
CIGNA CORPORATION | 1.5% |
XUHC.DE Underweight Relative to XDG3.DE
 |
NOVO NORDISK A/S-B | -4.9% |
 |
ASTRAZENECA PLC | -4.5% |
 |
SANOFI-AVENTIS | -3.0% |
|
GSK PLC | -2.9% |
|
VERTEX PHARMACEUTICALS INC | -2.7% |
|
BRISTOL-MYERS SQUIBB CO | -2.5% |
|
STRYKER CORP | -2.3% |
 |
ARGEN-X SE | -2.0% |
|
DANAHER CORP | -2.0% |
|
REGENERON PHARMACEUTICALS | -1.3% |